These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33)

  • 1. Effect of human erythrocyte stromata on complement activation.
    Corrocher R; Tedesco F; Rabusin P; De Sandre G
    Br J Haematol; 1975 Feb; 29(2):235-41. PubMed ID: 33
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of complement by stroma from normal and paroxysmal nocturnal haemoglobinuria red cells.
    De Sandre G; Corrocher R; Falezza GC; Aprili G; Caffi S
    Scand J Haematol; 1978 Mar; 20(3):265-70. PubMed ID: 644255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by acid-activated serum.
    Hänsch G; Hammer C; Jiji R; Rother U; Shin M
    Immunobiology; 1983 Mar; 164(2):118-26. PubMed ID: 6852860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnal hemoglobinuria.
    Chua C; Hoffmann EM; Adams JP; Rosse WF
    Blood; 1980 May; 55(5):772-6. PubMed ID: 7362868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the alternative pathway of complement by pH.
    Fishelson Z; Horstmann RD; Müller-Eberhard HJ
    J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. 3. The membrane defects caused by complement lysis.
    Rosse WF; Dourmashkin R; Humphrey JH
    J Exp Med; 1966 Jun; 123(6):969-84. PubMed ID: 5941785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.
    Rosse WF; Logue GL; Adams J; Crookston JH
    J Clin Invest; 1974 Jan; 53(1):31-43. PubMed ID: 4855546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of human erythrocytes due to activation of the alternate complement pathway by nephritic factor (C3NeF).
    Arroyave CM; Vallota EH; Müller-Eberhard HJ
    J Immunol; 1974 Sep; 113(3):764-8. PubMed ID: 4547248
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of heparin on complement activation and lysis of paroxysmal nocturnal hemoglobinuria (PNH) red cells.
    Logue GL
    Blood; 1977 Aug; 50(2):239-47. PubMed ID: 17439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ Complement activation by the alternate pathway (or properdin pathway) in paroxysmal nocturnal hemoglobinuria].
    Audran R
    Rev Fr Transfus; 1974 Dec; 17(4):333-48. PubMed ID: 4464553
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential errors in the laboratory diagnosis of paroxysmal nocturnal hemoglobinuria.
    Harruff RC; Rohn RJ
    Am J Clin Pathol; 1983 Aug; 80(2):152-8. PubMed ID: 6881089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Ferrone S; Marubini E; Mercuriali F; Sirchia G
    Br J Haematol; 1972 Jul; 23(1):5-12. PubMed ID: 5045962
    [No Abstract]   [Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells.
    Rouault TA; Rosse WF; Bell S; Shelburne J
    Blood; 1978 Feb; 51(2):325-30. PubMed ID: 620087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.
    May JE; Rosse W; Frank MM
    N Engl J Med; 1973 Oct; 289(14):705-9. PubMed ID: 4727529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.